Abstract | BACKGROUND: CASE PRESENTATION: Our patient is a 2 year old male with hypotonia, global developmental delay, and focal epilepsy. Trio whole-exome sequencing revealed heterozygous variants in PIGN, c.181G > T (p.Glu61*) and c.284G > A (p.Arg95Gln). Analysis of FLAER and anti-CD59 by flow-cytometry demonstrated a shift in this patient's granulocytes, confirming a glycosylphosphatidylinositol-biosynthesis defect, consistent with PIGN-related disease. CONCLUSIONS: To date, a total of 18 patients have been reported, all but 2 of whom have congenital anomalies and/or obvious dysmorphic features. Our patient has no significant dysmorphic features or multiple congenital anomalies, which is consistent with recent reports linking non-truncating variants with a milder phenotype, highlighting the importance of functional studies in interpreting sequence variants.
|
Authors | Isabelle Thiffault, Britton Zuccarelli, Holly Welsh, Xuan Yuan, Emily Farrow, Lee Zellmer, Neil Miller, Sarah Soden, Ahmed Abdelmoity, Robert A Brodsky, Carol Saunders |
Journal | BMC medical genetics
(BMC Med Genet)
Vol. 18
Issue 1
Pg. 124
(11 02 2017)
ISSN: 1471-2350 [Electronic] England |
PMID | 29096607
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- PIGN protein, human
- Phosphotransferases
|
Topics |
- Abnormalities, Multiple
(genetics)
- Child, Preschool
- DNA Mutational Analysis
- Developmental Disabilities
(genetics)
- Epilepsies, Partial
(genetics)
- Exome
(genetics)
- Genetic Predisposition to Disease
(genetics)
- Humans
- Male
- Muscle Hypotonia
(genetics)
- Mutation
- Phosphotransferases
(genetics)
|